Pricing Log in Create free account
Saturday 7 November 2026 Export BSEM’s income statement to Excel — free account

BioStem Technologies, Inc.

BSEM Healthcare Biotechnology

Revenue
−28.0%
EPS
−86,766.7%

Quarter to June 2026, against a year earlier

1.13 0.09 +8.65%
Market cap
$19.4M
P/E
0.0×
Fwd P/E
−0.6×
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE
Full definition →

+8 more TTM periods

 0.00% 0.00% 0.00% 0.00%
ROA
Full definition →
0.00% 0.00% 0.00% 0.00%
ROIC
Full definition →
0.00% 607.43% 0.00% 55.34%
Return on Tangible Assets
Full definition →
0.00% (13.81%) 0.00% (278.85%)
Average Days of Receivables
Full definition →
0.00 34.64 0.00 69.88
Free Cash Flow per Share
Full definition →
0.00 0.00 0.00 0.00
Other line items
Cash ROIC
Full definition →
— 0.00% — 0.00%
Accounts Receivable Turnover
Full definition →
0.00 0.00 0.00 0.00
Average Days of Payables
Full definition →
— 0.00 — 0.00
Days of Inventory on Hand
Full definition →
— 0.00 — 0.00
Tax Rate
Full definition →
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
Full definition →
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
Full definition →
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
Full definition →
0.00% 0.00% 0.00% 0.00%
Operating CF/Net income
Full definition →
0.00 0.00 0.00 0.00
Depreciation/Fixed assets
Full definition →
— 0.00 — 0.00
Revenue per Share
Full definition →
11.75 6.21 2.23 2.00
Operating CF per Share
Full definition →
0.00 0.00 0.00 0.00
Capex per Share
Full definition →
0.00 0.00 0.00 0.00
Capex to Sales
Full definition →
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026